CDMO Europe 2025 distinguishes itself as one of the most focused and strategic events in the bio-pharmaceutical sector across Europe. Unlike broader pharmaceutical conferences, this event zeroes in on the niche, yet critical, area of biopharma contract development and manufacturing, where the complexity and regulatory demands of biologics production require highly-specialised solutions.
Given the market's projected growth to nearly $30 billion by 2028, driven by the rising demand for biologics and biosimilars, the event offers unparalleled opportunities for companies to explore the latest innovations and form strategic partnerships. With major industry players like Boehringer Ingelheim and Lonza making significant investments in Europe, this conference provides a unique platform for CDMOs and biopharma companies to address the sector's most pressing challenges and opportunities in an intimate, highly-networked setting.
In a landscape where the development and manufacturing of biologics are becoming increasingly complex and essential, #CDMOEurope2025 stands out as the go-to event for companies aiming to streamline their operations, ensure regulatory compliance, and accelerate time-to-market for new therapies. This targeted focus and the emphasis on high-level networking set it apart from other conferences, making it an essential gathering for leaders in the biopharma contract manufacturing space.
WHO
This conference is designed for senior-level professionals across the biologics and advanced therapies outsourcing landscape, including C-Suite Executives, Heads, Directors, and Vice Presidents from CDMOs, biopharma companies, and regulatory agencies. Attendees represent expertise in manufacturing, quality, operations, supply chain, and strategic partnerships, with a strong focus on Europe’s most innovative and rapidly evolving markets.
WHAT
CDMO Europe 2025 provides a high-impact platform to explore the latest strategies, technologies, and partnerships shaping the future of contract development and manufacturing. With dedicated discussions on scalability, tech transfer, digital transformation, regulatory alignment, and next-gen facility models, the event brings together key stakeholders to share insights and accelerate value creation across the outsourcing ecosystem.
WHY
As demand for outsourced biologics and CGT manufacturing surges, Europe is emerging as a global hub for innovation, investment, and capacity expansion. CDMO Europe 2025 equips stakeholders with the knowledge and connections needed to stay competitive — from navigating evolving regulatory frameworks to leveraging digital and modular manufacturing models. By attending, participants gain first-hand access to market trends, partnership opportunities, and strategies to lead in a fast-changing manufacturing environment.
Key Themes & Topics
At the heart of CDMO EUROPE, the programme covers CDMO strategies, manufacturing innovation, and regulatory excellence:
CDMO Strategy & Capabilities:
Evaluating, optimising, and leveraging CDMOs for fast-track manufacturing and cost efficiency.
Manufacturing Innovation & Excellence:
Covering Quality by Design (QbD), Aseptic Fill-Finish, and Continuous Manufacturing for improved production outcomes.
Supply Chain & Risk Management:
Enhancing resilience, outsourcing strategies, and tech transfer to ensure seamless operations.
Regulatory & Compliance Challenges:
Addressing evolving global regulations, post-fill-finish hurdles, and quality assurance in external manufacturing.
Digital & AI Integration:
Leveraging Digital Twins, automation, and AI for smarter, more-efficient manufacturing processes.
Sustainability & Future Models:
Exploring Hybrid Manufacturing, Single-Use Technologies, and Carbon-Neutral Manufacturing for a sustainable future.
At the heart of CDMO EUROPE, the programme covers CDMO strategies, manufacturing innovation, and regulatory excellence:
CDMO Strategy & Capabilities:
Evaluating, optimising, and leveraging CDMOs for fast-track manufacturing and cost efficiency.
Manufacturing Innovation & Excellence:
Covering Quality by Design (QbD), Aseptic Fill-Finish, and Continuous Manufacturing for improved production outcomes.
Supply Chain & Risk Management:
Enhancing resilience, outsourcing strategies, and tech transfer to ensure seamless operations.
Regulatory & Compliance Challenges:
Addressing evolving global regulations, post-fill-finish hurdles, and quality assurance in external manufacturing.
Digital & AI Integration:
Leveraging Digital Twins, automation, and AI for smarter, more efficient manufacturing processes.
Sustainability & Future Models:
Exploring Hybrid Manufacturing, Single-Use Technologies, and Carbon-Neutral Manufacturing for a sustainable future.
300 max
Join the exclusive and strategic gathering that brings together the European biopharma contract development and manufacturing community, positioning them at the forefront of the global stage. Network with key decision-makers from contracts, research, and development companies.
30+
Gain insights from industry leaders on the complexity and regulatory demands of biologics production, highly-specialised solutions, the latest manufacturing technologies, co-development opportunities, process development know-how, and cost-reduction strategies in biologics manufacturing.
20+
Engage in dedicated networking sessions to exchange views, discuss industry insights, and explore collaboration opportunities with industry leaders and attendees from the bio-pharmaceutical sector.
8+
Dive deep into the latest innovations with select case studies and interactive sessions.
Join the exclusive and strategic gathering that brings together the European biopharma contract development and manufacturing community, positioning them at the forefront of the global stage. Network with key decision-makers from contracts, research, and development companies.
Gain insights from industry leaders on the complexity and regulatory demands of biologics production, highly-specialised solutions, the latest manufacturing technologies, co-development opportunities, process development know-how, and cost-reduction strategies in biologics manufacturing.
Engage in dedicated networking sessions to exchange views, discuss industry insights, and explore collaboration opportunities with industry leaders and attendees from the bio-pharmaceutical sector.
